From US FDA
Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food & Drug Administration (US FDA) for the extended-cycle oral contraceptive, Levonorgestrel/ Ethinyl Estradiol Tablets USP, 0.15 mg/ 0.03 mg, the AB rated generic version of Seasonale by Teva Women's Health.Seasonale is indicated for prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. According to IMS Health sales data for the 12 month period ending April 2015, the Seasonale market achieved sales of approximately $53.7 million.
Powered by Capital Market - Live News
